Clinical Trial Details
EORTC-1525-LCG
Back to Clinical Trials Database
Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemotherapy.
Trial Status | Closed to Patient Entry |
---|---|
Dates |
Date of activation: 12-Apr-2018 Date Step1 close: 25-Jan-2023 |
Data management at EORTC | Yes |
Design |
Phase 2 Not randomized / N.A. |
Targeted Sample size | EORTC Groups: 55 - All Groups: 55 |
Treatment |
Drug Ipilimumab, Nivolumab |
Study Staff |
Nicolas Girard (Study Coordinator) , Institut Curie- Hopital de Paris, PARIS CEDEX 05 Hadi Almidani (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Luc Boone (Statistician) , EORTC Headquarters, Brussels Ilse Coppens (Clinical Operations Assistant) , EORTC Headquarters, Brussels Amaya Gonzalez (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels Fanny Grillet (TR Scientist) , EORTC Headquarters, Brussels Selin Gundogan (Clinical Operations Manager) , EORTC Headquarters, Brussels Hafida Lmalem (Imaging Officer) , EORTC Headquarters, Brussels Belma Malanda (Project Manager) , EORTC Headquarters, Brussels Ana Oliveira (Data Manager) , EORTC Headquarters, Brussels Solange Peters (Study Co-Coordinator) , Centre Hospitalier Universitaire Vaudois - Lausanne, Lausanne Yassin Pretzenbacher (Statistician) , EORTC Headquarters, Brussels Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Jelle Stans (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Marian Stefanica (Clinical Operations Assistant) , EORTC Headquarters, Brussels Yuliya Vostrikova (Clinical Data Expert) , EORTC Headquarters, Brussels Zineb Wadid (Lead CRA) , EORTC Headquarters, Brussels Eleni Xenophontos (Clinical Research Physician) , EORTC Headquarters, Brussels |
Type of cancer | Thymoma |
Participating groups |
EORTC Lung Cancer Group ETOP IBCSG Partners Foundation |
Recruiting centers |
Academisch Ziekenhuis Maastricht (Maastricht, Netherlands) CHU de Grenoble - La Tronche - Hopital A. Michallon (GRENOBLE CEDEX 9, France) CHU de Lyon - Hopital Louis Pradel (BRON, France) CHU de Toulouse - Hopital Larrey (TOULOUSE CEDEX 9, France) Centre Francois Baclesse (CLCC) (CAEN CEDEX 5, France) Erasmus MC (Rotterdam, Netherlands) Gustave Roussy (VILLEJUIF CEDEX, France) Hopital Nord (APHM) (Marseille, France) Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain) Hospital Universitario 12 De Octubre (Madrid, Spain) Institut Curie- Hopital de Paris (PARIS CEDEX 05, France) Institut Jules Bordet (Anderlecht, Belgium) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) The Christie NHS Foundation Trust (Manchester, United Kingdom) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) Universitair Ziekenhuis Antwerpen (Edegem, Belgium) |
Protocol summary | http://clinicaltrials.gov/study/NCT03134118 |
NCT number | NCT03134118 |
EudraCT | 2015-005504-28 |
Financial Support | Educational Grant |